Antibodies | Free Full-Text | Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody
IJMS | Free Full-Text | Natural Killer Cells: Angels and Devils for Immunotherapy
A TCR-based Chimeric Antigen Receptor | Scientific Reports
In Pediatric Lymphoblastic Leukemia of B-Cell Origin, a Small Population of Primitive Blast Cells Is Noncycling, Suggesting Them to be Leukemia Stem Cell Candidates | Pediatric Research
CD3e Monoclonal Antibody (145-2C11), FITC (11-0031-82)
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation -
Purified anti-human CD3 Antibody anti-CD3 - SK7
IJMS | Free Full-Text | Cord Blood T Cells Expressing High and Low PKCζ Levels Develop into Cells with a Propensity to Display Th1 and Th9 Cytokine Profiles, Respectively
Semiconductor Nanoplatelets: A New Class of Ultrabright Fluorescent Probes for Cytometric and Imaging Applications | ACS Applied Materials & Interfaces
Cells | Free Full-Text | Adoptive Cellular Therapy for Multiple Myeloma Using CAR- and TCR-Transgenic T Cells: Response and Resistance
CD45R (B220) Monoclonal Antibody (RA3-6B2), eFluor™ 615 (42-0452-82)
Frontiers | Case Report: Cord blood-derived natural killer cells as new potential immunotherapy drug for solid tumor: a case study for endometrial cancer
Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL | Leukemia
T cell development in mice lacking the CD3-zeta/eta gene. - Abstract - Europe PMC
Targeting Prostate Cancer Using Bispecific T-Cell Engagers against Prostate-Specific Membrane Antigen | ACS Pharmacology & Translational Science
Frontiers | A novel trivalent non-Fc anti-CD3 Collabody preferentially induces Th1 cell apoptosis in vitro and long-lasting remission in recent-onset diabetic NOD mice
CB-5339 | p97 Inhibitor | MedChemExpress
Cancers | Free Full-Text | PD-1+CD8+ T Cells Proximal to PD-L1+CD68+ Macrophages Are Associated with Poor Prognosis in Pancreatic Ductal Adenocarcinoma Patients
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies | Nature Medicine
IJMS | Free Full-Text | Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy
Vaccines | Free Full-Text | Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies
Cancers | Free Full-Text | The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity
IJMS | Free Full-Text | Joining Forces for Cancer Treatment: From “TCR versus CAR” to “TCR and CAR”
Purified anti-mouse CD3 Antibody anti-CD3 - 17A2
Frontiers | Spatial distribution of CD3- and CD8-positive lymphocytes as pretest for POLE wild-type in molecular subgroups of endometrial carcinoma
Cells | Free Full-Text | Double Positive CD4+CD8+ (DP) T-Cells Display Distinct Exhaustion Phenotype in Chronic Hepatitis C
